Regulation of protease-activated receptor 1 (PAR 1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans

Thrombosis and Haemostasis

Volumn 90, Issue 5, 2003, Pages 898-903

  Reiter, Rosemarie ^a   Derhaschnig, Ulla ^a   Spiel, Alexander ^a   Keen, Priska ^a   Cardona, Francesco ^a   Mayr, Florian ^a   Jilma, Bernd ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endotoxin; P selectin; Platelet; Protease activated receptor; Thrombin

Indexed keywords

ANTIBODY; ENDOTOXIN; PADGEM PROTEIN; PROTEINASE ACTIVATED RECEPTOR 1; PROTHROMBIN; PROTHROMBIN FRAGMENT 1 + 2; SPAN12 ANTIBODY; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ENDOTOXEMIA; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOGENESIS;

EID: 0242438137     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-04-0245     Document Type: Article

References (25)

1. Lau LF, Pumiglia K, Cote YP, et al. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochem J 1994; 303: 391-400.
2. Vu TK, Hung DT, Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
3. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298-07.
4. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-87.
5. Brass LF, Pizarro S, Ahuja M, et al. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 1994; 269: 2943-52.
6. Mammen EF. The haematological manifestations of sepsis. J Antimicrob Chemother 1998; 41 (Suppl A): 17-24.
7. De Jonge E, Levi M, Stoutenbeek CP, et al. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 1998; 55: 767-77.
8. DeLa Cadena RA, Majluf-Cruz A, Stadnicki A, et al. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans. Thromb Haemost 1998; 80: 114-8.
9. Jilma B, Marsik C, Mayr F, et al. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin Pharmacol Ther 2002; 72: 403-10.
10. Hollenstein U, Homoncik M, Knobl P, et al. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans. Clin Pharmacol Ther 2002; 71: 368-74.
11. Stohlawetz P, Folman CC, Von Dem Borne AE, et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost 1999; 81: 613-7.
12. Jilma-Stohlawetz P, Folman CC, Von Dem Borne AE, et al. Effects of anticoagulation on thrombopoietin release during endotoxemia. J Lab Clin Med 2001; 137: 64-9.
13. Stohlawetz PJ, Dzirlo L, Hergovich N, et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000; 95: 2983-9.
14. 6 decreases thrombin receptor activating peptide-induced P-selectin expression. Blood Coagul Fibrinolysis 2003; 14: 131-8.
15. Molino M, Bainton DF, Hoxie JA, et al. Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation. J Biol Chem 1997; 272: 6011-7.
16. Dupont A, Fontana P, Bachelot-Loza C, et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 2003; 101: 1833-40.
17. Jilma B. Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-63.
18. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995; 21 (Suppl 2): 106-12.
19. Homoncik M, Blann AD, Hollenstein U, et al. Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100. Br J Haematol 2000; 111: 1250-2.
20. Trejo J, Altschuler Y, Fu HW, et al. Protease-activated receptor-1 down-regulation: A mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clathrin-coated pits. J Biol Chem 2000; 275: 31255-65.
21. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci 1996; 93: 11877-82.
22. Stohlawetz P, Horvath M, Pernerstorfer T, et al. Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans. Transfusion 1999; 39: 506-14.
23. Berger G, Hartwell DW, Wagner DD. P-selectin and platelets. Blood 1998; 92: 4446-52.
24. Gralnick HR, McKeown LP, Wilson OM, et al. von Willebrand factor release induced by endotoxin. J Lab Clin Med 1989; 113: 118-22.
25. Rinder HM, Tracey JB, Recht M, et al. Differences in platelet alpha-granule release between normals and immune thrombocytopenic patients and between young and old platelets. Thromb Haemost 1998; 80: 457-62.